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Xenopus XsalF: Anterior Neuroectodermal
Specification by Attenuating Cellular
Responsiveness to Wnt Signaling
initial step, the neuralizing signal from the organizer in-
duces neural differentiation in dorsal ectoderm along
the entire A-P axis (“activation” according to Nieuw-
koop). The important postulation in this model is that
neural tissues induced by the first signal acquire a fore-
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brain (archencephalic) identity. Following the activation,Kobe 650-0047
posterior CNS tissues are induced by the second signalJapan
that posteriorizes neural tissues (“transformation”).2 Department of Medical Embryology
Recent progress in molecular embryology has pro-Graduate School of Medicine
vided evidence that supports this model. The neuralKyoto University
inducers Noggin and Chordin (Chd) induce neural differ-Kyoto 606-8501
entiation from naive Xenopus ectoderm explants (animalJapan
caps); the induced neural tissues are of the forebrain
type (for review, see Sasai and De Robertis., 1997), con-
sistent with Nieuwkoop’s activation step. Wnt, FGF, and
Summary retinoic acid are shown to have posteriorizing activities
when combined with the neural inducers (McGrew et
Here we show that XsalF, a frog homolog of the Dro- al., 1995; Lamb and Harland, 1995; Cox and Hemmati-
sophila homeotic selector spalt, plays an essential role Brivanlou, 1995; Sasai et al., 1996; Kudoh et al., 2002).
for the forebrain/midbrain determination in Xenopus. However, the activation and transformation model in the
XsalF overexpression expands the domain of fore- A-P neural patterning may require some modifications.
brain/midbrain genes and suppresses midbrain/hind- In the embryo, endomesodermal tissues underlying ros-
brain boundary (MHB) markers and anterior hindbrain tral CNS secrete Wnt and Nodal antagonists that actively
genes. Loss-of-function studies show that XsalF is induce the forebrain tissues (e.g., Dkk1 and Cerberus;
essential for the expression of the forebrain/midbrain Glinka et al., 1998; Piccolo et al., 1999). Furthermore, a
genes and for the repression of the caudal genes. previous study using a neutralizing antibody has shown
Interestingly, XsalF functions by antagonizing canoni- that Dkk1 is required for forebrain development in the
cal Wnt signaling, which promotes caudalization of Xenopus embryo (Kazanskaya et al., 2000). These obser-
neural tissues. XsalF is required for anterior-specific vations indicate that the forebrain specification in vivo
expressions of GSK3 and Tcf3, genes encoding an- involves certain active processes.
tagonistic effectors of Wnt signaling. Loss-of-function Regarding the intracellular regulatory mechanism, a
phenotypes of GSK3 and Tcf3 mimic those of XsalF number of transcription factors have been implicated in
while injections of GSK3 and Tcf3 rescue loss-of- the regional specification of rostral CNS. Among them,
function phenotypes of XsalF. These findings suggest Otx2, En, Pax2, and Gbx2 have been shown to play
that the forebrain/midbrain-specific gene XsalF nega- essential roles in the establishment of forebrain-mid-
tively controls cellular responsiveness to posterio- brain-hindbrain regionalization during early embryogen-
rizing Wnt signals by regulating region-specific GSK3 esis (for review, see Simeone, 2000; Joyner et al., 2000).
Then, subregion-specific transcription factors such asand Tcf3 expression.
Bf1 (FoxG1) and Rx specify further regional characteris-
tics (Xuan et al., 1995; Mathers et al., 1997). During these
Introduction processes, tissue interactions between brain regions
are mediated by a number of secreted factors such as
Following neural induction initiated by the organizer, the Wnts, Shh, and FGFs (Shimamura and Rubenstein, 1997;
presumptive central nervous system (CNS) tissue of the Wilson and Rubenstein, 2000). In contrast, relatively little
vertebrate embryo acquires regional specificity along is known about early upstream events regulating ante-
the dorsal-ventral (D-V) and anterior-posterior (A-P) rior CNS specification.
axes. Classic embryological studies have indicated that Here we introduce a zinc finger transcription factor,
a number of inductive events are involved in CNS region- XsalF, which is expressed predominantly in presumptive
alization. As for A-P patterning in amphibians, dorsal anterior CNS during late gastrula and early neurula
blastopore lip tissues excised from early and late gas- stages. XsalF belongs to the protein family related to
trula stages possess head-inducing and trunk/tail- the product of the homeotic gene Drosophila spalt (sal),
inducing activities, respectively (head organizer and which specifies segment identities along the A-P axis
trunk/tail organizer; Mangold, 1933; Hamburger, 1988). in the head and tail of fly embryos (Ju¨rgens, 1988). Al-
Based on transplantation studies, a model involving two though several vertebrate Sal-related proteins have
inductive signals was proposed for the A-P patterning been identified, no definite roles of the family factors
of amphibian CNS (Nieuwkoop, 1952a, 1952b). In the have been clarified in early vertebrate embryogenesis.
In the present study, we investigated the molecular regu-
lation of anterior brain specification by focusing on the*Correspondence: sasaicdb@mub.biglobe.ne.jp
function of XsalF. We report the requirement of XsalF3 Present Address: Department of Neurology, Graduate School of
Medicine, Kyoto University, Kyoto 606-8501, Japan. for the forebrain/midbrain determination in Xenopus. As
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a possible mechanism of action, we discuss the role of
the transcription factor XsalF in controlling transcrip-
tional “readiness” to posteriorizing secreted signals in
anterior neuroectoderm.
Results
Forebrain/Midbrain-Specific Expression of XsalF
in Xenopus Neurulae
A partial XsalF cDNA was originally isolated in a small-
scale screen based on in situ hybridization by using a
frog anterior neural plate cDNA library (Matsui et al.,
2000). We became interested in this clone because of its
anterior-specific expression during early neurula stages
(shown below). Sequence analysis of a full-length clone
revealed that it encoded a Sal-related zinc finger protein
(Figure 1A). We named it Xenopus SalF after its marked
expression in the Forebrain region. XsalF contains four
pairs of double zinc fingers (C2H2-type) and two single
zinc fingers (ten fingers in all). Sal box sequences, which
are commonly found in zinc fingers of the Sal family, are
also present in XsalF (Supplemental Figure S1 [http://
www.developmentalcell.com/cgi/content/full/7/1/
95/DC1]). The number and the arrangement of zinc fin-
gers in XsalF are closest to those in Xsal1, whereas the
primary amino acid sequences of zinc fingers are more
similar to those of mSall2.
Temporal and spatial expression patterns of XsalF
were analyzed by whole-mount in situ hybridization (Fig-
ures 1B–1I). XsalF expression was first detected at late
gastrula stage (stage 13) in anterior neuroectoderm (Fig-
ure 1B). In the mid-neurula stage (stage 15; Figure 1C),
strong XsalF expression was observed in anterior neural
plate. XsalF expression at stages 13 and 15 was limited
to the ectoderm (cross-section data not shown). Double
Figure 1. Structure and Expression Pattern of XsalFin situ hybridization analyses showed that XsalF expres-
(A) Percent identities of amino acid residues among XsalF and Salsion was located within the Sox2 neural plate (data not
family proteins. Highly conserved Zn finger domains are indicatedshown), which lay medially to Slug expression (neural
by solid box. The structure of the dominant-negative XsalF is showncrest; Figure 1D). The anterior border of XsalF expres-
on the top. Amino acid residue numbers are indicated above.
sion coincided with that of Bf1 expression (data not (B–I) Temporal and spatial expression of XsalF analyzed by whole-
shown) and lay dorsally to the dorsal limit of XAG1 ex- mount in situ hybridization. (B) Stage 13. (C) Stage 15. (D–I) Double-
pression (cement gland; Figure 1E). The posterior border labeled in situ hybridization. (D) Slug (blue) and XsalF (indigo)
probes. (E) XAG1 (blue) and XsalF (indigo) probes. (F) Otx2 (blue)of strong XsalF expression coincided with the posterior
and XsalF (indigo) probes. (G) Tcf3 (blue) and XsalF (indigo) probes.borders of Otx2, Tcf3, and Pax2 expressions (Figures
(H) Pax2 (indigo) and XsalF (blue) probes. (I) Gbx2 (blue) and XsalF1F–1H). Little overlapping was found between XsalF and
(indigo) probes. (B, C, H, and I) Dorsal views with the anterior side
Gbx2 expressing areas (Figure 1I; von Bubnoff et al., up, (D–G) anterior view with the dorsal side up. (F and G) Arrows
1996). These results show that XsalF is a Spalt-related indicate the posterior borders.
transcription factor expressed in the presumptive fore-
brain/midbrain region during late gastrula and early neu- n  40; Figures 2C and 2D), and Bf-1 (telencephalon;
rula stages when brain regions are being specified. 70%, n  24; not shown; Bourguignon et al., 1998). The
Starting with the mid-neurula stage, XsalF expression expansion of these anterior markers prompted us to
was also detected in parts of more caudal CNS tissues analyze the effect on caudal neural markers. XsalF injec-
(data not shown). tion suppressed expression of Pax2 (MHB; 56%, n 
25; Figures 2E and 2F), En2 (MHB; 58%, n  31; not
XsalF Overexpression Induces Forebrain/ shown; Hemmati-Brivanlou et al., 1991), Wnt1 (MHB;
Midbrain Genes and Suppresses 52%, n  25; not shown), and Gbx2 (anterior hindbrain;
MHB/Hindbrain Genes 52%, n  25; Figures 2G and 2H), whereas it caused
We first examined gain-of-function phenotypes by in- little change in the expression of MafB (posterior hind-
jecting XsalF mRNA (400 pg) into two unilateral animal brain; n  40; Figures 2I and 2J; Ishibashi and Yasuda,
blastomeres of 8-cell embryos. XsalF injection induced 2001) and HoxB9 (spinal cord; n39; not shown). Similar
moderate but significant unilateral expansion of the fore- induction and suppression were observed when XsalF
brain/midbrain expression of Otx2 (forebrain/midbrain; was overexpressed via injection of an expression plas-
mid (pCS2-XsalF; not shown). These results indicate that67%, n  42; Figures 2A and 2B), Pax6 (forebrain; 63%,
Forebrain/Midbrain Determination by Xenopus XsalF
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Figure 2. Microinjection of XsalF mRNA Induces Expansion of Forebrain/Midbrain Markers and Suppression of MHB/Hindbrain Markers
XsalF mRNA (400 pg) was injected into two left animal blastomeres of 8-cell embryos. Embryos were harvested at the neurula stage. (A–L)
Analyzed by whole-mount in situ hybridization with the following probes. (A and B) Otx2 probe, anterior view with the dorsal side up; (C and
D) Pax6, anterior view; (E and F) Pax2, anterior view; (G and H) Gbx2, anterior view; (I and J) MafB, dorsal view with the anterior side up; (K
and L) MyoD, dorsal view. (A–D) Arrowheads indicate the midline.
XsalF induces forebrain/midbrain development at the embryo, the injected embryos exhibited a marked reduc-
tion of anterior CNS structures including eyes (64%, ncost of MHB/anterior hindbrain development.
To determine whether the effects of XsalF overexpres- 22; Figure 3A). During late neurula stages, the forebrain/
midbrain markers such as Pax6 (78%, n  46; Figuression acted directly on the neuroectoderm, we then ex-
amined the expression of mesodermal and endome- 3B and 3C), Otx2 (72%, n  50; Figures 3E and 3F and
Supplemental Figure S2A), Bf-1 (64%, n  25; Figuressodermal markers in XsalF-injected embryos. XsalF
injection did not significantly change the expression of 3G and 3H), and Rx (eye field; 78%, n  23; not shown)
were strongly suppressed in the XsalF-delC-injectedMyoD (paraxial mesoderm, n  38; Figures 2K and 2L),
Chd (axial mesoderm, n  24; not shown; Sasai et al., embryos. The suppression of Pax6 in the forebrain was
rescued by coinjecting wild-type XsalF (no suppression1994), or Crescent (anterior endomesoderm, n 20; not
shown; Pera and De Robertis, 2000), suggesting that in 90%, n  40; Figures 3C and 3D). By contrast, the
expression areas of the MHB markers En2, Pax2, andmesodermal and endomesodermal development was
largely unaffected. Wnt1 and the anterior hindbrain marker Gbx2 expanded
anteriorly in XsalF-delC-injected embryos (60%, n  30;
66%, n  32; 70%, n  30; Figures 3I–3L, and Supple-XsalF Is Essential for the Determination
of the Presumptive Forebrain/Midbrain Region mental Figures S2B–S2F). XsalF-delC injection did not
significantly affect expression of the posterior hindbrainWe next investigated the requirement of XsalF for the
regional determination of the CNS by performing loss- marker MafB (n  25), the spinal cord marker HoxB9
(n  20), the general neural marker Sox2 (n  42), theof-function studies. We first constructed a dominant-
negative form of XsalF by deleting nine zinc fingers (leav- mesodermal markers MyoD and Chd (n  25 and 22),
or the endomesodermal marker Frzb and Crescent (n ing the amino-terminal portion and one zinc finger;
XsalF-delC; Figure 1A, top). Similar carboxyl-terminal 23 and 21; data not shown).
To understand the temporal requirement of XsalFdeletion mutants have been shown to work as dominant-
negative proteins for other Sal family members (Sweet- functions, we conducted conditional inhibition experi-
ments by using XsalF-delC fused with a glucocorticoidman et al., 2003). Consistently, coinjection assays
showed that XsalF-delC suppressed XsalF-induced receptor ligand binding domain (XsalF-delC-GR), which
works as an inhibitory factor in a dexamethasone (Dex)-expansion of Otx2 expression in the embryo (data not
shown), indicating that XsalF-delC can antagonize the dependent manner (Tada et al., 1997). In the absence
of Dex, injection of XsalF-delC-GR did not affect Pax6wild-type function. When XsalF-delC mRNA was in-
jected alone into all animal blastomeres of the 8-cell expression (n 30; Figure 3M). When Dex was added to
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Figure 3. Attenuation of XsalF Function Re-
sults in Suppression of Forebrain/Midbrain
Marker Genes and Upregulation of MHB/
Anterior Hindbrain Genes
(A) External phenotypes caused by injecting
the dominant-negative XsalF (XsalF-delC).
Top, control sibling. (B–N) Effects of XsalF-
delC and XsalF-delC-GR injection. XsalF-
delC (50 pg; [C, D, F, H, J, L]) and XsalF (400
pg; [D]) mRNA were injected into all animal
blastomeres in 8-cell embryos. (M and N)
XsalF-delC-GR (50 pg) was injected into two
unilateral blastomeres and Dex was added at
stage 13 (N). Embryos were harvested at late
neurula stage and analyzed by whole-mount
in situ hybridization with the following probes
(anterior views): (B, C, D, M, N) Pax6 probe,
(E and F) Otx2, (G and H) Bf1, (I and J) En2,
(K and L) Pax2.
(O) External phenotypes caused by injecting
XsalF-MO. Top, control sibling. (P–Z) XsalF-
MO injection experiments. XsalF-MO (10 ng;
[Q, R, T, V, X, Z]), five base-mispaired control
MO (10 ng; [P]) and XsalF mRNA (400 pg; [R])
were injected.
Embryos were harvested at the neurula stage
and analyzed by whole-mount in situ hybrid-
ization with the following probes (anterior
views with the dorsal side up). (P, Q, R) Pax6
probes, (S and T) Otx2, (U and V) Bf1, (W and
X) En2, (Y and Z) Pax2.
the culture medium at stage 13 (the onset of endogenous XsalF-A and -B. Injection of XsalF-MO into four animal
blastomeres of the 8-cell embryo gave similar results toXsalF expression) or stage 16, the forebrain expression
of Pax6 was strongly suppressed at the late neurula those in the dominant-negative study; reduction of eye
and head structures (100%, n 24; Figure 3O), suppres-stage (94%, n  31; 67%, n  28, respectively; Figure
3N and not shown) while the MHB marker Pax2 was sion of the forebrain/midbrain markers Pax6, Otx2, and
Bf-1 (80%, n  35; 63%, n  24; 60%, n  40; Figuresexpanded anteriorly (54%, n  28; not shown). These
results show that the forebrain/midbrain region is cau- 3P, 3Q, and 3S–3V), and upregulation of the MHB and
anterior hindbrain markers En2, Pax2, Wnt1, and Gbx2dalized when the function of XsalF (and/or closely re-
lated Sal factors) is blocked during early/mid-neurula (70%, n  60; 85%, n  52; 68%, n  56; and 62% n 
29; Figures 3W–3Z and data not shown). Injection of MOstages.
To examine whether the phenotypes caused by XsalF- with 5-base mismatch caused no changes in the gene
expression (Figure 3P and data not shown; n  20). ThedelC injection were specific to the inhibition of XsalF
(and not due to the inhibition of related Sal factors), we suppression of Pax6 expression caused by XsalF-MO
was reversed when wild-type XsalF mRNA (which over-next conducted an additional loss-of-function study by
using morpholino antisense oligonucleotides (MO) spe- laps with XsalF-MO in only six bases) was coinjected
(46%, n 35; Figures 3Q and 3R). XsalF-MO caused nocific to XsalF. XsalF has two different pseudoalleles,
XsalF-A and -B, which are expressed in a similar manner significant changes in the mesodermal and endomeso-
dermal markers (data not shown). The results of the(data not shown). Therefore, we designed a MO (XsalF-
MO) complimentary to the conserved sequence of dominant-negative and MO studies demonstrate that
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the XsalF function is essential for the expression of fore-
brain-midbrain genes and the inhibition of ectopic ex-
pression of MHB and hindbrain genes in the pro-
cencephalon and mesencephalon.
Taken together with the overexpression results, these
observations show that XsalF is an essential regulator
for determining the presumptive forebrain/midbrain re-
gion in the neural plate during neurula stages.
XsalF Antagonizes Wnt Signaling and Is Essential
for Anterior-Specific Transcription
of GSK3 and Tcf3
We next investigated the mechanism of the XsalF func-
tion in the determination of the rostral CNS. Previous
studies have shown that Wnt-related signaling plays a
major role in the A-P patterning of rostral CNS (McGrew
et al., 1995; Kiecker and Niehrs, 2001; Houart et al.,
2002). Interestingly, the following observations sug-
gested that XsalF possessed inhibitory effects on Wnt
signals. Microinjection of a Wnt1-expression vector
(pCS2-wnt1) inhibited the forebrain expression of Pax6
(suppressed in 95%, n  20; Figures 4A and 4B) in vivo.
This inhibition was reversed by coinjection of XsalF (no
suppression in 61%, n 49; Figure 4C), suggesting that
XsalF antagonized Wnt signaling in the downstream of
Wnt1. The inhibition of the Wnt activity was also ob-
served in the animal cap explant (Figure 4D). In animal
caps neuralized by Chd injection (which contain mainly
forebrain tissues; Sasai et al., 1996), Otx2 and Six3 (Zhou
et al., 2000) expression was suppressed by Wnt injection
while the caudal markers En2 and Krox20 were induced
(lanes 3 and 4). These effects of Wnt were reversed by
coinjection of XsalF (lane 5).
The canonical Wnt pathway involves a cascade of
inhibitory regulators in the downstream intracellular sig-
naling (Nusse, 1999). Among them, GSK3 and Tcf3
have been shown to antagonize Wnt signaling, at least
in certain contexts (He et al., 1995; Brannon et al., 1997;
Roose et al., 1998). As XsalF antagonizes Wnt signaling
in the downstream of Wnt1 (Figures 4A–4C), one possi-
bility is that the transcription factor XsalF is involved in
the control of GSK3 and Tcf3 gene expression. We
became interested in this idea particularly because their
expression patterns in the neurula embryo appeared
unique as described below.
Whole-mount in situ hybridization with neurula em-
bryos showed that GSK3 mRNA was expressed pre-
dominantly in the anterior region (Figure 4E). Injection
of XsalF-MO into four animal blastomeres of the 8-cell
MO ([F, G, J, K]; 10 ng) and XsalF mRNA ([G and K]; 400 pg) were
injected into all animal blastomeres of 8-cell embryos and embryos
Figure 4. XsalF Antagonizes the Wnt Activity and Is Required for were analyzed by whole-mount in situ hybridization with GSK3-
Anterior-Specific Expression of GSK3 and Tcf3 ([E–G]; dorsal view with the anterior side up; cleared embryos) and
(A–C) Effects of overexpression of Wnt1 and XsalF on Pax6 expres- Tcf3 ([I–K]; anterior view) probes at the mid-neurula stage.
sion (anterior view). (B and C) pCS2-Wnt1 (5 pg) and XsalF (C) mRNA (H) RT-PCR analysis of GSK3- expression in the whole embryo
(400 pg) were injected into all animal blastomere of 8-cell embryos. (lane 1), anterior and posterior halves of the stage 15 embryo (lanes
Embryos were analyzed at the neurula stage. 2 and 3), XsalF-MO-injected and XsalF-MOXsalF mRNA-injected
(D) Animal caps were prepared from stage 10 embryos injected with embryos (lanes 4 and 5).
Chd (50 pg), Chd (50 pg)XWnt3a(50 pg), or ChdXWnt3aXsalF (L) Animal caps were prepared from stage 10 embryos injected with
(400 pg) mRNA, cultured until siblings reached at late neurula stage, Chd mRNA (50 pg), Chd mRNAXsalF-MO (10 ng), Chd mRNAX-
and analyzed by RT-PCR. salF-MOXsalF mRNA (400 pg), cultured until siblings reached at
(E–G and I–K) Transcriptional regulations of GSK3 and Tcf3. XsalF- late neurula stage, and analyzed by RT-PCR.
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embryo caused a significant suppression of GSK3 ex- Figures S3G and S3H; Stambolic et al., 1996; Klein and
Melton, 1996).pression in the anterior region (suppressed in 89%, n 
62; Figure 4F). This suppression was reversed by coin- These observations indicated that the gain-of-func-
tion and loss-of-function phenotypes of GSK3 largelyjection of XsalF mRNA (no suppression in 69%, n  48;
Figure 4G). These results indicate that the predominant overlapped with those of XsalF. This prompted us to
test whether GSK3 could rescue the loss-of-functionanterior expression of GSK3 is dependent on XsalF.
RT-PCR analysis also supported this idea. GSK3 ex- phenotype of XsalF. Pax6 expression in the forebrain
was strongly downregulated by injecting XsalF-delCpression levels were found to be much higher in the
anterior half of neurula embyos than in the posterior half mRNA (69%, n  32; Figures 5M and 5N); this inhibition
was reversed by coinjecting a GSK3-expression plas-(Figure 4H, lanes 2 and 3). This high expression was
suppressed by injection of XsalF-MO (lanes 4 and 5). mid (pCS2-GSK3; 81%, n  26; Figure 5O). This result
indicates that GSK3 is sufficient to substitute for theConsistent with previous reports, Tcf3 expression was
strongly expressed in anterior neural plate of neurula XsalF function in regulation of the forebrain gene.
These observations support the idea that XsalF-embryos (Figure 4I; Molenaar et al., 1998; Kim et al.,
2000). This anterior expression of Tcf3 was suppressed dependent GSK3 transcription is a crucial downstream
event in the anterior brain determination by XsalF.by XsalF-MO (suppressed in 69%, n  32; Figure 4J),
and the MO-induced suppression was reversed by injec-
tion of XsalF mRNA (no suppression in 63%, n  30;
Figure 4K). XsalF-Dependent Tcf3 Expression Plays a Critical
Role in XsalF FunctionsThese observations show that the expressions of
GSK3 and Tcf3 in the anterior region require the XsalF We next examined the functional relationship between
XsalF and Tcf3. Previous mutant studies in zebrafishactivity. The requirement of XsalF for GSK3 and Tcf3
expression was recapitulated in the animal cap assay. have suggested that the headless gene product Tcf3 is
an essential positive regulator of forebrain development.Expressions of GSK3 and Tcf3 in animal caps neu-
ralized by Chd were suppressed by injection of XsalF- In forebrain development, Tcf3 acts as an “inhibitor” of
canonical Wnt signaling and promotes anteriorization ofMO and rescued by coinjection of XsalF mRNA (Figure
4L, lanes 3–5). neural tissues (Kim et al. 2000), whereas Tcf3 “activates”
Wnt signaling in the axis formation (Molenaar et al.,
1996). Injection of Tcf3 mRNA in the two unilateral animalGSK3 Acts in the Downstream of XsalF
cells of 8-cell embryos expanded Otx2 and Pax6 expres-To further understand the role of GSK3 and Tcf3 in the
sion in the anterior CNS on the injected side (62%, n XsalF function, we performed gain-of-function and loss-
21; 35%, n  20; Figures 6A and 6B), whereas it sup-of-function studies. Injection of GSK3 caused similar
pressed Pax2 and Gbx2 expression at the MHB andphenotypes to those caused by injection of XsalF mRNA,
hindbrain (82%, n 22; 92%, n 24; Figures 6C and 6D).expansion of the forebrain/midbrain markers Otx2, Pax6,
In contrast, injection of dominant-negative Tcf3 (Tcf3-and XsalF, and suppression of the hindbrain and MHB
delC; lacking the carboxyl-terminal portion and blockingmarkers Pax2, Gbx2, and En2 (84%, n  25; 93%, n 
the inhibiting function of Tcf3 on Wnt signaling; Hamilton30; 90%, n21; 91%, n  35; 73%, n  30; and 97%,
et al., 2001; Kim et al., 2000) caused suppression ofn  30, respectively; Figures 5A–5D and not shown).
Otx2 and Pax6 (69%, n  32; 90%, n  20; Figures 6E,We next performed loss-of-function studies by using
6F, 6H, and 6I) and expansion of Pax2 at the MHB (57%,GSK3-MO. We avoided use of the dominant-negative
n  21; Figures 6J and 6K). Suppression of Otx2 by theGSK3 because its injection caused double axis forma-
dominant-negative Tcf3 was reversed by coinjection oftion as previously reported (He et al., 1995), probably
wild-type Tcf3 (no suppression in 93%, n  30; Figuresby competing with maternally provided GSK3 protein.
6F and 6G). Similar results were obtained by injectingIn contrast, injection of GSK3-MO did not affect axis
Tcf3MO, whereas the opposite results were seen withformation, probably because GSK3-MO is supposed
overexpression of Tcf3delN, which lacks the amino-ter-to block de novo synthesis of zygotic GSK3 protein.
minal portion and is known to block the activator func-Marker analyses showed that injection of GSK3-MO
tion of Tcf3 on Wnt signaling (Molenaar et al., 1996;inhibited the expression of Otx2, Pax6, Six3, Tcf3, and
Supplemental Figures S4A–S4N). These observationsXsalF (suppressed in 68%, n  41; 67%, n  24; and
demonstrate that the gain-of-function and loss-of-func-91%, n  22; Figures 5E, 5F, and 5I–5L and Supple-
tion phenotypes of Tcf3 mimic those of XsalF.mental Figures S3A–S3F). Suppression of Otx2 by
We next tested whether Tcf3 could rescue a loss-of-GSK3-MO was reversed by wild-type GSK3 (no sup-
function phenotype of XsalF. Suppression of Pax6 andpression in 89%, n  35; Figure 5G), but not by XsalF
Otx2 expression by the dominant-negative XsalF (sup-(n 32; Figure 5H). GSK3-MO injection expanded Wnt1
pressed in 75%, n  20; 72%, n  29, respectively) wasexpression at the MHB (Supplemental Figures S3A and
reversed by coinjection of Tcf3 (no suppression in 90%,S3B). However, unlike XsalF-delC injection, GSK3-MO
n  51; 75%, n  20, respectively; Figures 6L–6Q). To-injection did not effectively expand Gbx2 expression
gether with the observation that strong anterior Tcf3(n  34; data not shown). However, this might be due
transcription is XsalF dependent (Figure 4J), these re-to the quantitative level of GSK3 inhibition, since signif-
sults suggest that Tcf3 transcription is also a functionalicant expansion of Gbx2 expression was observed when
downstream target of XsalF in the regional determina-late gastrula embryos were treated with LiCl, which is
a potent GSK3 inhibitor (70%, n  20; Supplemental tion of the anterior CNS.
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Figure 5. Effects of GSK3 and GSK3-MO on A-P Patterning
(A–D) Gain-of-function of GSK3. GSK3 mRNA (200 pg) was injected into two left animal blastomeres of 8-cell embryos.
(E–L) GSK3-MO ([F–H, J, and L]; 10 ng), GSK3 mRNA ([G]; 200 pg), and XsalF mRNA ([H]; 400 pg) were injected into all animal blastomeres
of 8-cell embryos.
(M–O) Injection of XsalF-delC mRNA ([N and O]; 50 pg) and pCS2-GSK3 DNA ([O]; 200 pg). Embryos were harvested at the neurula stage
and analyzed by whole-mount in situ hybridization with the following probes (anterior views): (A, E–H) Otx2 probe, (B, I, J, M–O) Pax6, (C)
Pax2, (D) Gbx2, (K and L) Six3.
GSK3 and Tcf3 Rescue Loss-of-Function rescued the loss-of-function phenotype of XsalF in the
ectodermal explant without mesodermal influences.Phenotypes of XsalF in the Neuralized
Ectodermal Explant To further understand interactions of XsalF, GSK3,
and Tcf3 in Wnt signaling, we performed a luciferaseTo ask whether XsalF regulates anterior CNS develop-
ment directly in the ectoderm, we conducted loss-of- assay in neuralized animal caps by using the TOPFLASH
reporter for canonical Wnt signaling. In Chd-injectedfunction experiments by using the neuralized animal cap
explant. Chd-injected animal caps expressed the fore- caps, injection of XsalF-delC caused significant aug-
mentation of luciferase activity (Figure 7W, lane 2) whilebrain/midbrain markers Otx2 (100%, n  22; Figure 7B)
and XsalF (100%, n  21; Figure 7V), but not the MHB coinjections of GSK3 and Tcf3 suppressed the in-
crease (lanes 3 and 4), supporting the idea that XsalFmarker Pax2 (n  20; Figure 7G). Consistent with the
in vivo results (Figure 3), coinjection of XsalF-delC sup- interacts with Wnt signaling upstream of GSK3 and
Tcf3. These observations further support the idea thatpressed Otx2 expression (suppressed in 100%, n  20;
Figure 7C) while it induced Pax2 (expressed in 95%, n GSK3 and Tcf3 are candidate players of XsalF signaling
in the inhibition of the canonical Wnt pathway.22; Figure 7H). This demonstrates that XsalF is required
for anterior specification of neuralized animal cap cells. As shown above (Figures 5–7), each of GSK3 and
Tcf3 can rescue the loss-of-function phenotypes ofThe inhibition of Otx2 and the induction of Pax2 were
reversed by coinjecting GSK3 (expressed in 75%, n  XsalF. The rescue of the XsalF loss-of-function by
GSK3 alone, however, seems somewhat contradictory20; 0%, n  23, respectively; Figures 7D and 7I) and by
coinjecting Tcf3 (expressed in 100%, n  20, 0%; n  to the conventional epistatic logics, since both GSK3
and Tcf3 expressions are suppressed upon inhibiting20, respectively; Figures 7E and 7J). None of XsalF-delC,
GSK3, and Tcf3 injections affected the expression of XsalF (Figure 4) and Tcf3 is suggested to act down-
stream of GSK3 (Nusse, 1999). In this respect, we ex-the pan-neural marker Sox2 (n  20 each; Figures 7L–
7O), nor did they induce the mesodermal makers MyoD amined possible crossregulation between GSK3 and
Tcf3. We found that GSK3 and Tcf3 transcriptionally(n  20 each; Figures 7P–7T). Thus, GSK3 and Tcf3
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Figure 6. Effects of Tcf3 and Tcf3-delC on
A-P Patterning
Tcf3 mRNA ([A–D]; 10 pg) was injected into
two left animal blastomeres of 8-cell em-
bryos. Tcf3-delC mRNA ([F, G, I, K]; 10 pg),
XsalF-delC ([M, N, P, Q]; 50 pg), and Tcf3
mRNA ([G, N, Q]; 10 pg) were injected into all
animal blastomeres of 8-cell stage embryos.
Embryos were harvested at the neurula stage
and analyzed by whole-mount in situ hybrid-
ization with the following probes (anterior
view): (A, E–G, and O–Q) Otx2 probe, (B, H, I,
L–N) Pax6, (C, J, K) Pax2, (D) Gbx2.
activated each other in neuralized animal caps, even in signals through high levels of expression of the antago-
the presence of XsalF-delC (Figures 7X and 7Y). This nistic mediators GSK3 and Tcf3. GSK3 and Tcf3 are
may explain, at least in part, the mechanism of the res- expressed predominantly in anterior neural plate, and
cue by the upstream factor. Consistent with this mutual their expressions require XsalF activities. The gain-of-
activation, Tcf3 expression is suppressed by GSK3MO function and loss-of-function phenotypes of GSK3 and
in the embryo (Supplemental Figure S3D) while GSK3 Tcf3 mimic those of XsalF in the A-P specification. Each
expression is inhibited by Tcf3-delC (Supplemental Fig- of GSK3 and Tcf3 rescues the loss-of-function pheno-
ures S4P and S4Q). types of XsalF, showing that transcriptional controls of
GSK3 and Tcf3 are important downstream events of
XsalF signaling.Discussion
Gene interactions between XsalF and GSK3/Tcf3/
Wnt appear to be complex and involve potential feed-XsalF-Dependent Transcription of GSK3
back loops. For instance, Tcf3, which is activated byand Tcf3 Is Crucial for Anterior
XsalF, is required for XsalF expression in the forebrain/Neuroectodermal Determination
midbrain at the early neurula stage (Supplemental Fig-The present study has introduced the transcription fac-
ures S4M–S4O). This may serve as one of the feedbacktor XsalF as a regulator of forebrain/midbrain determina-
loops that maintain the regional identity. This idea is intion in the Xenopus embryo. An interesting aspect of
good accordance with in vivo expressions of XsalF andXsalF is that it actively alters the competence to extra-
Tcf3, which show substantial overlapping (Figure 1G).cellular patterning signals. Overexpression of XsalF an-
Feedback loops are also found between Wnt1 and XsalF.tagonizes the posteriorizing effect of Wnt1 (Figure 4).
Wnt1 overexpression suppresses XsalF (SupplementalAttenuation of XsalF (Figure 3) gives similar phenotypes
Figures S6A and S6B) while XsalF negatively regulatesto those caused by Wnt1 overexpression, showing that
Wnt1. Interestingly, regulation of Tcf3 expression bythe XsalF and Wnt signals act in reciprocal directions
XsalF is unlikely to depend on this Wnt inhibition. XsalFregarding the A-P patterning of the CNS. XsalF appears
to make the cells resistant to the posteriorizing Wnt activates Tcf3 expression in the presence of forced Wnt1
Forebrain/Midbrain Determination by Xenopus XsalF
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Figure 7. XsalF Is Required for Anterior Iden-
tity of Neuralized Animal Caps
Animal caps were prepared from stage 10
embryos that had been injected with control
mRNA (A, F, K, P, U), Chd mRNA ([B, G, L, Q,
V]; 100 pg), XsalF-delC (100 pg)Chd mRNAs
(C, H, M, R), GSK3 mRNA (100 pg)XsalF-
delCChd mRNAs (D, I, N, S), or Tcf3 (10
pg)XsalF-delCChd mRNAs (E, J, O, T). An-
imal caps were harvested at the time equiva-
lent to stage 15 and hybridized with Otx2
(A–E), Pax2 (F–J), Sox2 (K–O), MyoD (P–T),
and XsalF (U and V) probes. After in situ hy-
bridization, animal caps were refixed with
Bouin’s solution and cleared in benzyl alco-
hol/benzyl benzoate (1:2). (W) Animal caps
were prepared from stage 10 embryos that
had been injected with Chd (lanes 1–8), con-
trol (lanes 1 and 5), XsalF-delC (lanes 2–4 and
6–8), GSK3- (lanes 3 and 7), and Tcf3 (lanes
4 and 8) mRNAs. The embryos were also in-
jected with 50 pg TOPFLASH (lanes 1–4) or
negative control FOPFLASH (lanes 5–8) vec-
tor and 0.1 pg phRL vector (loading control)
in addition to indicated RNAs. Injected animal
caps were cultured until siblings reached at
the late neurula stage and analyzed for lucif-
erase activity following the manufacturer’s
protocol. (X and Y) Animal caps were pre-
pared from stage 10 embryos injected with
Chd (50 pg), Chd (50 pg)XsalF-delC (50 pg),
ChdXsalF-delCGSK3 (200 pg) or Chd
XsalF-delCTcf3 (10 pg) mRNA, then cul-
tured until siblings reached late neurula stage
and analyzed by RT-PCR.
expression, which would repress Tcf3 expression unless XsalF for anterior CNS specification (including the for-
mation of this possible feedback loop) should be attrib-XsalF is coinjected (Supplemental Figures S5A–S5D).
Unlike the case with Tcf3, GSK3 expression is not uted to stages at and after late gastrulation. To under-
stand these complex in vivo gene interactions, detailedinduced by XsalF in neuralized animal cap overexpress-
ing Wnt1 (Supplemental Figure S5D). Unfortunately, be- “stage-by-stage” analyses should be necessary in fu-
ture investigation.cause of technical limitation in sensitivity, we have not
succeeded in detecting precise distribution of XsalF and
GSK3 expressions by double in situ hybiridization.
Therefore, at this moment, careful consideration may Role of XsalF in the Forebrain/Midbrain
Determination and Its Molecular Mechanismbe needed for interpretation of in vivo significance of
GSK3 regulation by XsalF. XsalF is required for two aspects of region-specific tran-
scriptional regulations: activation of the forebrain/mid-Otx2 and XsalF seem to maintain their expressions in
the forebrain/midbrain region by forming another mutual brain genes and suppression of the MHB/hindbrain
genes. Interestingly, these two aspects of XsalF require-activation loop. Our preliminary studies have shown that
Otx2 overexpression induces XsalF expression in vivo ments could be uncoupled in certain conditions. When
the XsalF function is partially inhibited by injecting(Supplemental Figure S6C). At the same time, XsalF is
essential and sufficient for Otx2 expression (Figures 2 XsalF-A-specific MO (which does not hybridize with
XsalF-B), the forebrain/midbrain markers such as Otx2and 3). The onset of XsalF expression is at the late
gastrula stage (Figure 1). Therefore, the requirement of were effectively suppressed whereas the MHB markers
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such as En2 and Wnt1 expression were largely unaf- sal is positively regulated by a dpp morphogen gradient
in fly wing development (Nellen et al., 1996), while XsalFfected (Supplemental Figure S7).
These observations suggest two intriguing facts. First, is induced in the animal cap by the BMP antagonist Chd
(Figure 7V). Although both genes are controlled by BMPthe activation of forebrain/midbrain genes and the sup-
pression of MHB/hindbrain genes have distinct sensitivi- signaling, the direction of regulation is opposite and,
therefore, comparison of the upstream regulation seemsties to the gene dosage of XsalF. The former is affected
even when only one pseudoallele (A ) is knocked down to require careful consideration.
while the latter is impaired only if both pseudoalleles A
Experimental Proceduresand B are attenuated. XsalF may utilize distinct mecha-
nisms in the activation of forebrain/midbrain genes and
Isolation of XsalF cDNA
in the suppression of MHB/hindbrain genes. A lambda phage library of random-primed partial cDNAs was gener-
Second (and more importantly), these observations ated by using Xenopus anterior neural plate mRNA (stage 13–14)
indicate that XsalFMO is unlikely to suppress forebrain/ as described previously (Matsui et al., 2000). Several dozen clones
were picked up in a random manner and their insert cDNAs weremidbrain markers secondarily via its induction of ectopic
amplified by PCR. By using these cDNAs as templates for cRNAWnt1 expression. Consistent with this idea, XsalFMO
probes, a small-scale whole-mount in situ hybridization screen wassuppresses Otx2 and induces Pax2 in neuralized animal
conducted with multiple stage embryos. One cDNA clone exhibited
caps regardless of the presence of the Wnt antagonist an intriguing expression pattern in anterior CNS and was chosen
Dkk1 (Supplemental Figures S8D, S8E, S8I, and S8J). for isolation of full-length cDNAs and further analysis.
Our preliminary experiments by using the conven-
tional fusion chimera strategy have shown that VP16- Embryonic Manipulation
Embryos were staged according to the normal table of Nieukoopfused and EnR-fused XsalF exhibit the same activity with
and Faber. Injection of synthetic RNA was done with a fine glassthe wild-type and dominant-negative XsalF, respectively
capillary and a pneumatic pressure injector (Narishige) in 1Barth’s(our unpublished data). This finding suggests that XsalF
solution. The embryos were then transferred into 0.1Barth’s solu-
acts as an activator in this context. This idea indicates tion until further manipulation or harvesting. For mRNA injection,
that at least suppression of caudal CNS markers by the plasmids were linearized with NotI and transcribed with SP6
XsalF should be indirectly mediated by downstream re- polymerase (mMessage mMachine, Ambion). For animal cap
assays, tissues were excised at stage 10 and cultured in 1LCMRpressors, and goes along with our idea of involvement
supplemented with 0.2% BSA until the indicated stage. For LiClof Tcf3 in the downstream of XsalF. Understanding of
treatment, stage 13 embryos were incubated with 300 mM LiCl inmore detailed gene regulations by XsalF, including dis-
0.1Barth’s solution (Klein and Melton, 1996) for 12 min. All experi-
tinction between direct and indirect ones, must await ments were performed at least twice to confirm reproducibility.
future investigation. It would be intriguing to systemati-
cally elucidate the downstream gene cascade of XsalF Plasmid Construction and Morpholino Oligonucleotides
A cDNA fragment containing the full coding sequence of XsalF-Ain the brain specification, for instance, by using DNA
was subcloned into pCS2 vector at EcoRI/XhoI sites (pCS2-XsalF).chips and neuralized animal caps with and without
To generate the XsalF-delC construct, a cDNA coding the amino-XsalF-MO injection. A simplified summary scheme of
terminal part of XsalF (residues 1–55) was amplified by PCR andgene interactions deduced from this study is presented
subcloned into the pCS2-NLS vector. pCS2-XsalF-delC-GR was
in Supplemental Figure S9. constructed by fusing the human glucocorticoid receptor ligand
binding domain to the XsalF-delC (Tada et al., 1997). The entire
coding region of GSK3- and Tcf3 was amplified by RT-PCR fromSpeculations on Possible
stage 17 embryo cDNA and subcloned into the pCS2 vector at theEvolutionary Conservation
EcoRI/XhoI site. The dominant-negative Tcf3 (dnTcf3) was con-In Drosophila, sal plays essential roles in a number of
structed as described previously (Hamilton et al., 2001).
developmental aspects, including A-P specification and The morpholino antisense oligonucleotides were designed as fol-
wing development (Ju¨rgens, 1988; Nellen et al., 1996). lows: (XsalF) 5-CGACATCTCCACCACTCCTAATTGT-3, (XsalF-A-
specific) 5-GGTAAAATCTGATCTCTCCTACGGT-3 and (GSK3-)Particularly, in early fly embryogenesis, sal functions as
5-CTCACCTCCTTCTCTTCTAGATCAA-3, (Tcf3) 5-GCCGCTGTTGa homeotic gene that is essential for head specification
AGCTGAGGCATGATG-3.(Ju¨rgens, 1988; Ku¨hnlein et al., 1994). In sal mutants,
posterior head segments are transformed into anterior
In Situ Hybridization and RT-PCR Analyses
thoracic structures (“posterior transformation” of the Whole-mount in situ hybridization and RT-PCR analyses were per-
head segments). At the molecular level, the sal mutation formed as described previously (Mizuseki et al., 1998; Sasai et al.,
induces ectopic expression of the trunk-specific homeo- 2001). PCR primers used first in this study analysis are as follows:
Six3 (forward primer, ATGGTGTTCAGGTCCCCTCT; reverse primer,tic gene teashirt (tsh; Ro¨der et al., 1992) in the head. In
CAGGGATGGACTCGTGTTTATTAATGG), GSK3- (forward primer,Xenopus, the loss-of-function phenotype of XsalF in-
ATGAGCGGAAGGCCGAGAACCACTTC; reverse primer, GAACAGvolves ectopic expression of the posterior CNS genes
GTGATACATGTACAAGACAGTTTCGG) and Tcf3 (forward primer,
at the cost of anterior ones (Figure 3). In this regard, ATGCCTCAGCTCAACAGCGGCGGCGG; reverse primer, ATCTCG
sal and XsalF seem to share similar functions in A-P GATCATCAGG), XsalF (forward primer, GTGCTGGGCAAGAAACC
patterning of rostral regions across species. A recent AAACC reverse primer; GTTGTTGTTGCAAAACGCAGC).
report shows that mTsh1, a mammalian homolog of Dro-
Luciferase Assayssophila tsh (a negative target gene of fly sal), is ex-
For luciferase assays, the TOPFLASH reporter vector (Upstate, NY)pressed in the hindbrain and spinal cord, but not in
for Wnt signaling was injected into animal blastomeres of 8-cellmore rostral CNS (Caubit et al., 2000). It is intriguing to
embryos together with a loading control plasmid and testing
examine in future study whether vertebrate tsh counter- mRNAs. The FOPFLASH vector (containing mutations in the Lef
parts are controlled by vertebrate sal-related genes. binding sites) was used as a control luciferase reporter. Animal caps
were excised at stage 10, cultured until the indicated stage, andWith regard to signals controlling gene expression,
Forebrain/Midbrain Determination by Xenopus XsalF
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subjected to luciferase assays using the Dual-Luciferase Reporter Klein, P.S., and Melton, D.A. (1996). A molecular mechanism for
the effect of lithium on development. Proc. Natl. Acad. Sci. USAAssay System (Promega).
93, 8455–8459.
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